<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Amgen - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XplW2QpAMNYAAK@7PjMAAACS","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Amgen","wgTitle":"Amgen","wgCurRevisionId":950859604,"wgRevisionId":950859604,"wgArticleId":932897,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Amgen","wgRelevantArticleId":932897,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Amgen_Inc.","wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,
"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Amgen","wgWikibaseItemId":"Q470517","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},
"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Amgenheadquarters.jpg/1200px-Amgenheadquarters.jpg"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Amgen&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Amgen&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Amgen"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Amgen rootpage-Amgen stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Amgen" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Amgen" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Amgen</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Amgen" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Amgen" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Amgen&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"><span class="mw-redirectedfrom">&#160;&#160;(Redirected from <a href="/w/index.php?title=Amgen_Inc.&amp;redirect=no" class="mw-redirect" title="Amgen Inc.">Amgen Inc.</a>)</span></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0">
<p><b>Amgen Inc.</b> (formerly <b>A</b>pplied <b>M</b>olecular <b>Gen</b>etics Inc.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup><sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup>) is an American multinational <a href="/wiki/Biopharmaceutical" title="Biopharmaceutical">biopharmaceutical</a> <a href="/wiki/Corporation" title="Corporation">company</a> headquartered in <a href="/wiki/Thousand_Oaks,_California" title="Thousand Oaks, California">Thousand Oaks, California</a>. One of the world's largest independent <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> companies, Amgen was established in <a href="/wiki/Thousand_Oaks,_California" title="Thousand Oaks, California">Thousand Oaks, California</a> in 1980.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup><sup id="cite_ref-Baker,_Pam_2002_Page_37_8-0" class="reference"><a href="#cite_note-Baker,_Pam_2002_Page_37-8">[8]</a></sup> Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in <a href="/wiki/Ventura_County,_California" title="Ventura County, California">Ventura County</a>.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup><sup id="cite_ref-Baker,_Pam_2002_Page_37_8-1" class="reference"><a href="#cite_note-Baker,_Pam_2002_Page_37-8">[8]</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">[10]</a></sup> Focused on <a href="/wiki/Molecular_biology" title="Molecular biology">molecular biology</a> and <a href="/wiki/Biochemistry" title="Biochemistry">biochemistry</a>, its goal is to provide a healthcare business based on <a href="/wiki/Recombinant_DNA_technology" class="mw-redirect" title="Recombinant DNA technology">recombinant DNA technology</a>.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">[11]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Amgen Inc.</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Amgen.svg" class="image"><img alt="Amgen.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Amgen.svg/250px-Amgen.svg.png" decoding="async" width="250" height="64" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Amgen.svg/375px-Amgen.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Amgen.svg/500px-Amgen.svg.png 2x" data-file-width="167" data-file-height="43"></a></td></tr><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Amgenheadquarters.jpg" class="image"><img alt="Amgenheadquarters.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Amgenheadquarters.jpg/250px-Amgenheadquarters.jpg" decoding="async" width="250" height="176" data-file-width="4904" data-file-height="3456"></a><div>Amgen headquarters in <a href="/wiki/Thousand_Oaks,_California" title="Thousand Oaks, California">Thousand Oaks, California</a></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Formerly</div></th><td class="nickname" style="line-height: 1.35em;">Applied Molecular Genetics<br>(1980–1983)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><a href="/wiki/NASDAQ" class="mw-redirect" title="NASDAQ">NASDAQ</a>: <a rel="nofollow" class="external text" href="https://www.nasdaq.com/symbol/amgn">AMGN</a><br><a href="/wiki/NASDAQ-100" title="NASDAQ-100">NASDAQ-100 Component</a><br><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100 Component</a><br><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500 Component</a><br><a href="/wiki/Hong_Kong_Stock_Exchange" title="Hong Kong Stock Exchange">SEHK</a>: <a rel="nofollow" class="external text" href="https://www.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote?sym=4332&amp;sc_lang=en">4332</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US0311621009">US0311621009 </a><a href="https://www.wikidata.org/wiki/Q470517?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Biotechnology" title="Biotechnology">Biotechnology</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1980<span class="noprint">; 40 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1980</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;"><a href="/wiki/Thousand_Oaks,_California" title="Thousand Oaks, California">Thousand Oaks, California</a>, <a href="/wiki/United_States" title="United States">U.S.</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><a href="/wiki/Robert_A._Bradway" title="Robert A. Bradway">Robert A. Bradway</a><br><small>(<a href="/wiki/Chairman" class="mw-redirect" title="Chairman">Chairman</a>, <a href="/wiki/President_(corporate_title)" title="President (corporate title)">President</a>, and <a href="/wiki/CEO" class="mw-redirect" title="CEO">CEO</a>)</small></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Products</th><td style="line-height: 1.35em;"><a href="/wiki/Aimovig" class="mw-redirect" title="Aimovig">Aimovig</a>, <a href="/wiki/Aranesp" class="mw-redirect" title="Aranesp">Aranesp</a>, <a href="/wiki/Blincyto" class="mw-redirect" title="Blincyto">Blincyto</a>, <a href="/wiki/Epogen" class="mw-redirect" title="Epogen">Epogen</a>, <a href="/wiki/Anakinra" title="Anakinra">Kineret</a>, <a href="/wiki/Enbrel" class="mw-redirect" title="Enbrel">Enbrel</a>, <a href="/wiki/Kyprolis" class="mw-redirect" title="Kyprolis">Kyprolis</a>, <a href="/wiki/Neulasta" class="mw-redirect" title="Neulasta">Neulasta</a>, <a href="/wiki/Neupogen" class="mw-redirect" title="Neupogen">Neupogen</a>, <a href="/wiki/Nplate" class="mw-redirect" title="Nplate">Nplate</a>, <a href="/wiki/Parsabiv" class="mw-redirect" title="Parsabiv">Parsabiv</a>, <a href="/wiki/Prolia" class="mw-redirect" title="Prolia">Prolia</a>, <a href="/wiki/Repatha" class="mw-redirect" title="Repatha">Repatha</a>, <a href="/wiki/Sensipar" class="mw-redirect" title="Sensipar">Sensipar</a>/<a href="/wiki/Mimpara" class="mw-redirect" title="Mimpara">Mimpara</a>, <a href="/wiki/Vectibix" class="mw-redirect" title="Vectibix">Vectibix</a> and <a href="/wiki/Xgeva" class="mw-redirect" title="Xgeva">Xgeva</a>.</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/United_States_dollar" title="United States dollar">US$</a> 23.4 billion (2019)<sup id="cite_ref-Snapshotfinancials2018_1-0" class="reference"><a href="#cite_note-Snapshotfinancials2018-1">[1]</a></sup><sup id="cite_ref-PMfinancials2018_2-0" class="reference"><a href="#cite_note-PMfinancials2018-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$9.79 billion (2016)<sup id="cite_ref-filings2016_3-0" class="reference"><a href="#cite_note-filings2016-3">[3]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$7.72 billion (2016)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$77.63 billion (2016)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> US$29.88 billion (2016)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">22,000 (February 2020)<sup id="cite_ref-quickfacts2020_4-0" class="reference"><a href="#cite_note-quickfacts2020-4">[4]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://www.amgen.com">www<wbr></wbr>.amgen<wbr></wbr>.com</a></span></td></tr></tbody></table><p>In 2018, the company's largest selling product lines were <a href="/wiki/Neulasta" class="mw-redirect" title="Neulasta">Neulasta</a>, an <a href="/wiki/Immunostimulator" class="mw-redirect" title="Immunostimulator">immunostimulator</a> used to prevent infections in patients undergoing cancer chemotherapy and <a href="/wiki/Enbrel" class="mw-redirect" title="Enbrel">Enbrel</a>, a <a href="/wiki/Tumor_necrosis_factor" class="mw-redirect" title="Tumor necrosis factor">tumor necrosis factor</a> blocker used in the treatment of <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> and other autoimmune diseases. Other products include <a href="/wiki/Epogen" class="mw-redirect" title="Epogen">Epogen</a>, <a href="/wiki/Darbepoetin" class="mw-redirect" title="Darbepoetin">Aranesp</a>, <a href="/wiki/Sensipar" class="mw-redirect" title="Sensipar">Sensipar</a>/<a href="/wiki/Mimpara" class="mw-redirect" title="Mimpara">Mimpara</a>, <a href="/wiki/Nplate" class="mw-redirect" title="Nplate">Nplate</a>, <a href="/wiki/Vectibix" class="mw-redirect" title="Vectibix">Vectibix</a>, <a href="/wiki/Prolia" class="mw-redirect" title="Prolia">Prolia</a> and <a href="/wiki/Denosumab" title="Denosumab">XGEVA</a>.<sup id="cite_ref-PMfinancials2018_2-1" class="reference"><a href="#cite_note-PMfinancials2018-2">[2]</a></sup> Amgen sponsors the <a href="/wiki/Tour_of_California" title="Tour of California">Tour of California</a>.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup></p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Timeline"><span class="tocnumber">2</span> <span class="toctext">Timeline</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Acquisition_timeline"><span class="tocnumber">3</span> <span class="toctext">Acquisition timeline</span></a>
<ul><li class="toclevel-2 tocsection-4"><a href="#Acquisition_history"><span class="tocnumber">3.1</span> <span class="toctext">Acquisition history</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-5"><a href="#Products"><span class="tocnumber">4</span> <span class="toctext">Products</span></a>
<ul><li class="toclevel-2 tocsection-6"><a href="#Products_developed_and_then_sold_off"><span class="tocnumber">4.1</span> <span class="toctext">Products developed and then sold off</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-7"><a href="#Pipeline_and_clinical_trials"><span class="tocnumber">5</span> <span class="toctext">Pipeline and clinical trials</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<div class="thumb tright"><div class="thumbinner" style="width:181px;"><a href="/wiki/File:AMGenelogo.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/en/b/b7/AMGenelogo.jpg" decoding="async" width="179" height="150" class="thumbimage" data-file-width="179" data-file-height="150"></noscript><span class="lazy-image-placeholder" style="width: 179px;height: 150px;" data-src="//upload.wikimedia.org/wikipedia/en/b/b7/AMGenelogo.jpg" data-alt="" data-width="179" data-height="150" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:AMGenelogo.jpg" class="internal" title="Enlarge"></a></div>AMGen corporate logo, 1983</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:G5-N551GA-070919-04cr-16.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/G5-N551GA-070919-04cr-16.jpg/220px-G5-N551GA-070919-04cr-16.jpg" decoding="async" width="220" height="146" class="thumbimage" data-file-width="1600" data-file-height="1061"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 146px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/G5-N551GA-070919-04cr-16.jpg/220px-G5-N551GA-070919-04cr-16.jpg" data-alt="" data-width="220" data-height="146" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:G5-N551GA-070919-04cr-16.jpg" class="internal" title="Enlarge"></a></div>Amgen's corporate <a href="/wiki/Gulfstream_V" title="Gulfstream V">Gulfstream V</a> departs <a href="/wiki/Fox_Field" class="mw-redirect" title="Fox Field">Fox Field</a>, <a href="/wiki/Lancaster,_California" title="Lancaster, California">Lancaster, California</a></div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Macri_Amgen.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Macri_Amgen.jpg/220px-Macri_Amgen.jpg" decoding="async" width="220" height="202" class="thumbimage" data-file-width="1920" data-file-height="1764"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 202px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ad/Macri_Amgen.jpg/220px-Macri_Amgen.jpg" data-alt="" data-width="220" data-height="202" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Macri_Amgen.jpg" class="internal" title="Enlarge"></a></div>Argentine president <a href="/wiki/Mauricio_Macri" title="Mauricio Macri">Mauricio Macri</a> meets with heads of Amgen, in 2018</div></div></div>
<p>The word <b>AMGen</b> is a <a href="/wiki/Portmanteau" title="Portmanteau">portmanteau</a> of the company's original name, <b>A</b>pplied <b>M</b>olecular <b>Gen</b>etics, which became the official name of the company in 1983 (three years after incorporation and coincident with its <a href="/wiki/Initial_public_offering" title="Initial public offering">initial public offering</a>). The company's first <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a>, from 1980, was co-founder <a href="/wiki/George_Rathmann" title="George Rathmann">George B. Rathmann</a>, followed by <a href="/wiki/Gordon_Binder" title="Gordon Binder">Gordon M. Binder</a> in 1988,<sup id="cite_ref-Amgen-Mar-1998-10-K_13-0" class="reference"><a href="#cite_note-Amgen-Mar-1998-10-K-13">[13]</a></sup> followed by <a href="/wiki/Kevin_W._Sharer" title="Kevin W. Sharer">Kevin W. Sharer</a> in 2000.<sup id="cite_ref-Amgen-Mar-2000-10-K405_14-0" class="reference"><a href="#cite_note-Amgen-Mar-2000-10-K405-14">[14]</a></sup> Robert A. Bradway became Amgen’s president and chief executive officer in May 2012 following Sharer's retirement.<sup id="cite_ref-Amgen-May-2012-8-K_15-0" class="reference"><a href="#cite_note-Amgen-May-2012-8-K-15">[15]</a></sup></p><p>The company has made at least five major <a href="/wiki/Mergers_and_acquisitions" title="Mergers and acquisitions">corporate acquisitions</a>.
</p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Timeline">Timeline</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=2" title="Edit section: Timeline" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<ul><li>1980. William Bowes from Cetus Corporation recruits Winston Salser from UCLA to start Amgen with a scientific advisory board consisting of <a href="/wiki/Norman_Davidson_(biologist)" title="Norman Davidson (biologist)">Norman Davidson</a>, <a href="/wiki/Leroy_Hood" title="Leroy Hood">Leroy Hood</a>, <a href="/wiki/Arnold_Berk" title="Arnold Berk">Arnold Berk</a>, <a href="/wiki/John_Carbon" title="John Carbon">John Carbon</a>, <a href="/wiki/Robert_Schimke" title="Robert Schimke">Robert Schimke</a>, <a href="/wiki/Arno_Motulsky" title="Arno Motulsky">Arno Motulsky</a>, <a href="/wiki/Marvin_H._Caruthers" title="Marvin H. Caruthers">Marvin H. Caruthers</a>, and Dave Gibson.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">[16]</a></sup></li>
<li>1989. Amgen received approval for the first recombinant human erythropoetin product, Epogen, for the treatment of anemia associated with chronic kidney failure. Epogen (also marketed by Johnson and Johnson under the tradename Procrit) would later be approved for anemia due to cancer chemotherapy, anemia due to treatment with certain <a href="/wiki/HIV_drug_resistance" title="HIV drug resistance">HIV drugs</a>, and for the reduction of the need for transfusions associated with surgery.<sup id="cite_ref-auto_17-0" class="reference"><a href="#cite_note-auto-17">[17]</a></sup></li>
<li>1991. In February 1991, Amgen received FDA approval for Neupogen for the prevention of infections in patients whose immune systems are suppressed due to cancer chemotherapy.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup> A 2002 meta-analysis found that Neupogen treatment reduced the risk of febrile neutropenia by 38%, reduced the risk of documented infection by 49%, and reduced the risk of infection-related mortality by 40%.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup></li>
<li>1998. In November 1998, Immunex, a future acquisition of Amgen, received approval for Enbrel (etanercept), the first rheumatoid arthritis drug targeting tumor necrosis factor alpha (TNF-alpha).<sup id="cite_ref-auto_17-1" class="reference"><a href="#cite_note-auto-17">[17]</a></sup> A 2006 assessment by the National Institute of Clinical Excellence of the United Kingdom concluded that etanercept and related rheumatoid arthritis drugs later introduced by competitors "are effective treatments compared with placebo for RA patients who are not well controlled by conventional DMARDs, improving control of symptoms, improving physical function, and slowing radiographic changes in joints."<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup> A more recent study demonstrated that compared to traditional disease-modifying anti-rheumatic drugs, treatment with etanercept improved survival, reduced cardiovascular events and reduced the incidence of hematological cancers.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup></li>
<li>2010. On June 6, 2010 Amgen received <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> approval for Prolia, a protein drug for the treatment of post-menopausal osteoporosis.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup> In clinical trials, Prolia reduced the rate of vertebral fractures by 61% and the risk of hip fractures by 40%.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup></li>
<li>2010 In November 2010 the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> approved Xgeva for the prevention of complications of bone metastases in patients with solid tumors.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup> The clinical trials primarily enrolled patients with breast or prostate cancer.</li>
<li>2012. Illegal marketing practices. The <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i> reported on December 18, 2012 that Amgen pleaded guilty and agreed to pay $150 million in criminal penalty and $612 million to resolve 11 related <a href="/wiki/Whistleblower" title="Whistleblower">whistleblower</a> complaints. Federal prosecutors accused the company of pursuing profits while putting patients at risk.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup>  Larry Husten, a contributor at Forbes.com elaborates on AMGEN's illegal marketing practices in this case, namely that the "government accused Amgen of marketing Aranesp for indications not approved by the FDA and other illegal marketing practices".<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup> One of the drugs mentioned in the lawsuit had sales of $492 million in the third quarter of 2012, down 17% from the same quarter the previous year due to "reimbursement problems and label changes".<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup></li>
<li>2013. Lawmakers inserted text into the fiscal cliff bill that will allow the drugmaker to sell a class of drugs that includes Sensipar without government controls for an additional two years. The New York Times estimated that the paragraph in the fiscal cliff bill will cost taxpayers an estimated $500 million<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup> but other assessments concluded that the change would protect seniors in rural areas and reduce overall Medicare spending.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup></li>
<li>2015. In September the company announced it would acquire Dezima Pharma for more than $1.55 billion.<sup id="cite_ref-genengnews.com_31-0" class="reference"><a href="#cite_note-genengnews.com-31">[31]</a></sup> The same day the company announced a collaboration with Xencor on 6 early stage immuno-oncology and inflammation programmes. As part of the deal Amgen will pay $45 million upfront, with the deal being worth up to another $1.7 billion.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">[32]</a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup></li>
<li>2016. In September, the company announced it would purchase the rights to <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheims</a> Phase I bispecific T-cell engager compound (BI 836909, now AMG 420) for use in the treatment of <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup></li>
<li>2017. Cash returned to shareholders totalled a record $6.5 billion through dividends and share repurchases.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup></li>
<li>2018. Amgen was ranked 123 on the Fortune 500 list of the largest United States corporations by revenue. <sup id="cite_ref-36" class="reference"><a href="#cite_note-36">[36]</a></sup></li>
<li>2019. Amgen announced it would acquire Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million) to enhance its drug discovery capabilities.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup> In August the company announced it would acquire the <a href="/wiki/Otezla" class="mw-redirect" title="Otezla">Otezla</a> drug programme from <a href="/wiki/Celgene" title="Celgene">Celgene</a> for $13.4 billion, as part of Celgene and <a href="/wiki/Bristol-Myers_Squibb" title="Bristol-Myers Squibb">Bristol-Myers Squibbs</a> merger deal.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup> In October, Amgen announced it would be acquiring a 20.5% stake in the <a href="/wiki/Beijing" title="Beijing">Beijing</a>-based BeiGene for $2.7 billion.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Acquisition_timeline">Acquisition timeline</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=3" title="Edit section: Acquisition timeline" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;">
<ul><li>1994 – Synergen, Inc.<sup id="cite_ref-Amgen-Feb-1995-8-K/A_41-0" class="reference"><a href="#cite_note-Amgen-Feb-1995-8-K/A-41">[41]</a></sup></li>
<li>2000 – Kinetix Pharmaceuticals, Inc.<sup id="cite_ref-Amgen-Oct-2000-425_42-0" class="reference"><a href="#cite_note-Amgen-Oct-2000-425-42">[42]</a></sup></li>
<li>2002 – Immunex Corporation<sup id="cite_ref-Amgen-Dec-2001-8-K_43-0" class="reference"><a href="#cite_note-Amgen-Dec-2001-8-K-43">[43]</a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup></li>
<li>2004 – Tularik, Inc.<sup id="cite_ref-Amgen-Mar-2004-8-K_45-0" class="reference"><a href="#cite_note-Amgen-Mar-2004-8-K-45">[45]</a></sup></li>
<li>2006 – Abgenix, Inc.<sup id="cite_ref-Amgen-Dec-2005-8-K_46-0" class="reference"><a href="#cite_note-Amgen-Dec-2005-8-K-46">[46]</a></sup><sup id="cite_ref-Amgen-Apr-2006-8-K_47-0" class="reference"><a href="#cite_note-Amgen-Apr-2006-8-K-47">[47]</a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup></li>
<li>2006 – Avidia, Inc.<sup id="cite_ref-Amgen-Sep-2006-8-K_49-0" class="reference"><a href="#cite_note-Amgen-Sep-2006-8-K-49">[49]</a></sup></li>
<li>2007 – Alantos Pharmaceuticals<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup></li>
<li>2007 – Ilypsa, Inc.<sup id="cite_ref-Amgen-Aug-2007-10-Q_51-0" class="reference"><a href="#cite_note-Amgen-Aug-2007-10-Q-51">[51]</a></sup></li>
<li>2007 – Alantos Pharmaceuticals Holdings, Inc.<sup id="cite_ref-Amgen-Aug-2007-10-Q_51-1" class="reference"><a href="#cite_note-Amgen-Aug-2007-10-Q-51">[51]</a></sup></li>
<li>2011 – BioVex Group, Inc.<sup id="cite_ref-Amgen-Jan-2011-8-K_52-0" class="reference"><a href="#cite_note-Amgen-Jan-2011-8-K-52">[52]</a></sup></li>
<li>2011 – Laboratório Químico Farmacêutico Bergamo Ltda.<sup id="cite_ref-Amgen-May-2011-10-Q_53-0" class="reference"><a href="#cite_note-Amgen-May-2011-10-Q-53">[53]</a></sup></li>
<li>2012 – Micromet, Inc.<sup id="cite_ref-Amgen-Jan-2012-8-K_54-0" class="reference"><a href="#cite_note-Amgen-Jan-2012-8-K-54">[54]</a></sup></li>
<li>2012 – Mustafa Nevzat İlaç<sup id="cite_ref-Amgen-Apr-2012-8-K_55-0" class="reference"><a href="#cite_note-Amgen-Apr-2012-8-K-55">[55]</a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56">[56]</a></sup></li>
<li>2012 – KAI Pharmaceuticals<sup id="cite_ref-Amgen-May-2012-10-Q_57-0" class="reference"><a href="#cite_note-Amgen-May-2012-10-Q-57">[57]</a></sup></li>
<li>2012 – <a href="/wiki/DeCODE_genetics" title="DeCODE genetics">deCODE genetics</a></li>
<li>2013 – <a href="/wiki/Onyx_Pharmaceuticals" title="Onyx Pharmaceuticals">Onyx Pharmaceuticals</a> Inc.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">[58]</a></sup></li>
<li>2015 – Dezima Pharma<sup id="cite_ref-genengnews.com_31-1" class="reference"><a href="#cite_note-genengnews.com-31">[31]</a></sup></li>
<li>2015 – Catherex<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">[59]</a></sup></li></ul></div>
<h3 class="in-block"><span class="mw-headline" id="Acquisition_history">Acquisition history</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=4" title="Edit section: Acquisition history" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>The following is an illustration of the company's mergers, acquisitions, <a href="/wiki/Corporate_spin-off" title="Corporate spin-off">spin-offs</a> and historical predecessors:
</p>
<style data-mw-deduplicate="TemplateStyles:r935768785">.mw-parser-output table.clade{border-spacing:0;margin:0;font-size:100%;line-height:100%;border-collapse:separate;width:auto}.mw-parser-output table.clade table.clade{width:100%}.mw-parser-output table.clade td.clade-label{width:0.7em;padding:0 0.15em;vertical-align:bottom;text-align:center;border-left:1px solid;border-bottom:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-fixed-width{overflow:hidden;text-overflow:ellipsis}.mw-parser-output table.clade td.clade-fixed-width:hover{overflow:visible}.mw-parser-output table.clade td.clade-label.first{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-label.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-slabel{padding:0 0.15em;vertical-align:top;text-align:center;border-left:1px solid;white-space:nowrap}.mw-parser-output table.clade td.clade-slabel:hover{overflow:visible}.mw-parser-output table.clade td.clade-slabel.last{border-left:none;border-right:none}.mw-parser-output table.clade td.clade-slabel.reverse{border-left:none;border-right:1px solid}.mw-parser-output table.clade td.clade-bar{vertical-align:middle;text-align:left;padding:0 0.5em;position:relative}.mw-parser-output table.clade td.clade-bar.reverse{text-align:right;position:relative}.mw-parser-output table.clade td.clade-leaf{border:0;padding:0;text-align:left}.mw-parser-output table.clade td.clade-leafR{border:0;padding:0;text-align:right}.mw-parser-output table.clade td.clade-leaf.reverse{text-align:right}.mw-parser-output table.clade:hover span.linkA{background-color:yellow}.mw-parser-output table.clade:hover span.linkB{background-color:green}</style><table class="clade" style="font-size:90%;line-height:110%"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<p><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"></p>
<table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935768785"><table class="clade"><tbody><tr><td rowspan="2" class="clade-leaf reverse">
<p>Amgen<br><small>(Founded 1983 as Applied Molecular Genetics)</small>
</p>
</td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Synergen Inc<br><small>(Acq 1994)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Kinetix Pharmaceuticals Inc<br><small>(Acq 2000)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Immunex Corporation<br><small>(Acq 2002)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Tularik Inc <small>(Acq 2004)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Abgenix Inc<br><small>(Acq 2006)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Avidia Inc<br><small>(Acq 2006)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Alantos Pharmaceuticals<br><small>(Acq 2007)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Ilypsa Inc<br><small>(Acq 2007)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Alantos Pharmaceuticals Holdings Inc<br><small>(Acq 2007)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>BioVex Group Inc<br><small>(Acq 2011)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Laboratório Químico Farmacêutico Bergamo Ltda<br><small>(Acq 2011)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Micromet Inc<br><small>(Acq 2012)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Mustafa Nevzat İlaç<br><small>(Acq 2012)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>KAI Pharmaceuticals<br><small>(Acq 2012)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p><a href="/wiki/DeCODE_genetics" title="DeCODE genetics">deCODE genetics</a><br><small>(Acq 2012)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p><a href="/wiki/Onyx_Pharmaceuticals" title="Onyx Pharmaceuticals">Onyx Pharmaceuticals</a><br><small>(Acq 2013)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>NextCODE genetics<br><small>(Spun off 2013)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Dezima Pharma<br><small>(Acq 2015)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"> 
</td></tr><tr><td class="clade-slabel reverse"> 
</td></tr><tr><td rowspan="2" class="clade-leaf reverse">
<p>Catherex<br><small>(Acq 2015)</small>
</p>
</td>
<td class="clade-label reverse"> 
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></td>
<td class="clade-label first"><b>Amgen</b>
</td></tr><tr><td class="clade-slabel last"> 
</td></tr></tbody></table></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Products">Products</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=5" title="Edit section: Products" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<p>Amgen's <a href="/wiki/Approved_drug" title="Approved drug">approved drugs</a> or therapeutic biologicals include:
</p>
<ul><li class="mw-empty-elt">
<li>AIMOVIG (<a href="/wiki/Erenumab-aooe" class="mw-redirect" title="Erenumab-aooe">erenumab-aooe</a>) for <a href="/wiki/Migraine_headaches" class="mw-redirect" title="Migraine headaches">migraine headaches</a></li>
<li>Aranesp (<a href="/wiki/Darbepoetin_alfa" title="Darbepoetin alfa">darbepoetin alfa</a>) for <a href="/wiki/Anemia" title="Anemia">anemia</a></li>
<li>BLINCYTO (<a href="/wiki/Blinatumomab" title="Blinatumomab">blinatumomab</a> for the treatment of <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">acute lymphoblastic leukemia</a>)<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup></li>
<li>Corlanor (<a href="/wiki/Ivabradine" title="Ivabradine">ivabradine</a>)</li>
<li>Enbrel (<a href="/wiki/Etanercept" title="Etanercept">etanercept</a>) for various forms of <a href="/wiki/Arthritis" title="Arthritis">arthritis</a></li>
<li>EPOGEN (<a href="/wiki/Erythropoietin" title="Erythropoietin">erythropoietin</a>) for <a href="/wiki/Anemia" title="Anemia">anemia</a></li>
<li>EVENITY (<a href="/w/index.php?title=Romosozumab-aqqg&amp;action=edit&amp;redlink=1" class="new" title="Romosozumab-aqqg (page does not exist)">romosozumab-aqqg</a>) for <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a></li>
<li>IMLYGIC (<a href="/wiki/Talimogene_laherparepvec" title="Talimogene laherparepvec">talimogene laherparepvec</a>) for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in melanoma recurrent after initial surgery</li>
<li>Kyprolis (<a href="/wiki/Carfilzomib" title="Carfilzomib">carfilzomib</a>)</li>
<li>Neulasta (<a href="/wiki/Pegfilgrastim" title="Pegfilgrastim">pegfilgrastim</a>) for <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a></li>
<li>NEUPOGEN (<a href="/wiki/Granulocyte_colony-stimulating_factor" title="Granulocyte colony-stimulating factor">granulocyte colony-stimulating factor</a>) for <a href="/wiki/Neutropenia" title="Neutropenia">neutropenia</a></li>
<li>Nplate (<a href="/wiki/Romiplostim" title="Romiplostim">romiplostim</a>) for chronic <a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura">immune thrombocytopenic purpura</a></li>
<li>Parsabiv (<a href="/wiki/Etelcalcetide" title="Etelcalcetide">etelcalcetide</a>)</li>
<li>Prolia (<a href="/wiki/Denosumab" title="Denosumab">denosumab</a>) for postmenopausal <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a></li>
<li>Repatha (<a href="/wiki/Evolocumab" title="Evolocumab">evolocumab</a>)</li>
<li>Sensipar/Mimpara (<a href="/wiki/Cinacalcet" title="Cinacalcet">cinacalcet</a> for primary and <a href="/wiki/Secondary_hyperparathyroidism" title="Secondary hyperparathyroidism">secondary hyperparathyroidism</a>, a mineral metabolism complication common in patients with kidney failure)</li>
<li>Vectibix (<a href="/wiki/Panitumumab" title="Panitumumab">panitumumab</a> for <a href="/wiki/Colon_cancer" class="mw-redirect" title="Colon cancer">colon cancer</a>)</li>
<li>XGEVA (<a href="/wiki/Denosumab" title="Denosumab">denosumab</a>) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone in adults with bone metastases from solid tumors)</li></ul><h3 class="in-block"><span class="mw-headline" id="Products_developed_and_then_sold_off">Products developed and then sold off</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=6" title="Edit section: Products developed and then sold off" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<ul><li>Kepivance (<a href="/wiki/Palifermin" title="Palifermin">palifermin</a> for <a href="/wiki/Oral_mucositis" class="mw-redirect" title="Oral mucositis">oral mucositis</a>, sold to Biovitrium, now <a href="/wiki/Swedish_Orphan_Biovitrum" title="Swedish Orphan Biovitrum">Swedish Orphan Biovitrum</a>, in December 2008<sup id="cite_ref-BiovitriumDeal_61-0" class="reference"><a href="#cite_note-BiovitriumDeal-61">[61]</a></sup></li>
<li>StemGen (<a href="/wiki/Ancestim" title="Ancestim">ancestim</a>) for use in combination with <a href="/wiki/Filgrastim" title="Filgrastim">filgrastim</a> for mobilizing peripheral <a href="/wiki/Hematopoietic_stem_cells" class="mw-redirect" title="Hematopoietic stem cells">hematopoietic stem cells</a><sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup>) (sold to Biovitrium, now Swedish Orphan Biovitrum, in December 2008)<sup id="cite_ref-BiovitriumDeal_61-1" class="reference"><a href="#cite_note-BiovitriumDeal-61">[61]</a></sup></li>
<li>Kineret (<a href="/wiki/Anakinra" title="Anakinra">anakinra</a>) for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, exclusively licensed to Biovitrium, now Swedish Orphan Biovitrum, in December 2008<sup id="cite_ref-BiovitriumDeal_61-2" class="reference"><a href="#cite_note-BiovitriumDeal-61">[61]</a></sup></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Pipeline_and_clinical_trials">Pipeline and clinical trials</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=7" title="Edit section: Pipeline and clinical trials" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>As of December 2013, Amgen had 11 drugs in Phase III <a href="/wiki/Clinical_trials" class="mw-redirect" title="Clinical trials">clinical trials</a>.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup></p><p>In November 2014 the company announced it was halting all trials of <a href="/wiki/Rilotumumab" title="Rilotumumab">rilotumumab</a> in advanced <a href="/wiki/Gastric_cancer" class="mw-redirect" title="Gastric cancer">gastric cancer</a> patients after one of the trials found more deaths in those who took the compound with chemotherapy, than those without.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">[64]</a></sup> Later in the same week, the company (in conjunction with <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a>) reported positive results for <a href="/wiki/Brodalumab" title="Brodalumab">brodalumab</a> in a phase III trial comparing the compound with <a href="/wiki/Ustekinumab" title="Ustekinumab">ustekinumab</a> and a placebo in treating <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a>.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup></p><p>In March 2015, the company announced it would license its Phase II candidate drug <a href="/w/index.php?title=AMG_714&amp;action=edit&amp;redlink=1" class="new" title="AMG 714 (page does not exist)">AMG 714</a> to developer <a href="/w/index.php?title=Celimmune&amp;action=edit&amp;redlink=1" class="new" title="Celimmune (page does not exist)">Celimmune</a> who plan to develop the anti-IL-15 monoclonal antibody for treatment against diet nonresponsive celiac disease and refractory celiac disease.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">[66]</a></sup></p><p>In June 2015, Amgen presented Phase 2 clinical trial data for their anti-<a href="/wiki/CGRP" class="mw-redirect" title="CGRP">CGRP</a> antibody <a href="/wiki/AMG_334" class="mw-redirect" title="AMG 334">AMG 334</a> for <a href="/wiki/Migraine" title="Migraine">migraine</a>, approved for sale as AIMOVIG in 2019.<sup id="cite_ref-June2015_67-0" class="reference"><a href="#cite_note-June2015-67">[67]</a></sup></p><p>In 2019, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> has granted <a href="/wiki/Fast_track_designation" class="mw-redirect" title="Fast track designation">fast track designation</a> to <a href="/wiki/AMG_510" title="AMG 510">AMG 510</a> for the treatment of metastatic <a href="/wiki/Non-small-cell_lung_carcinoma" title="Non-small-cell lung carcinoma">non-small-cell lung carcinoma</a> with the G12C KRAS mutation.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68">[68]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=8" title="Edit section: See also" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<style data-mw-deduplicate="TemplateStyles:r936637989">.mw-parser-output .portal{border:solid #aaa 1px;padding:0}.mw-parser-output .portal.tleft{margin:0.5em 1em 0.5em 0}.mw-parser-output .portal.tright{margin:0.5em 0 0.5em 1em}.mw-parser-output .portal>ul{display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold}.mw-parser-output .portal>ul>li{display:table-row}.mw-parser-output .portal>ul>li>span:first-child{display:table-cell;padding:0.2em;vertical-align:middle;text-align:center}.mw-parser-output .portal>ul>li>span:last-child{display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle}</style><div role="navigation" aria-label="Portals" class="noprint portal plainlist tright">
<ul><li><span><noscript><img alt="flag" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Flag_of_California.svg/32px-Flag_of_California.svg.png" decoding="async" width="32" height="21" class="noviewer thumbborder" data-file-width="900" data-file-height="600"></noscript><span class="lazy-image-placeholder" style="width: 32px;height: 21px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Flag_of_California.svg/32px-Flag_of_California.svg.png" data-alt="flag" data-width="32" data-height="21" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Flag_of_California.svg/48px-Flag_of_California.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/01/Flag_of_California.svg/64px-Flag_of_California.svg.png 2x" data-class="noviewer thumbborder"> </span></span><span><a href="/wiki/Portal:California" title="Portal:California">California portal</a></span></li>
<li><span><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" decoding="async" width="28" height="28" class="noviewer" data-file-width="512" data-file-height="512"></noscript><span class="lazy-image-placeholder" style="width: 28px;height: 28px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/28px-Industry5.svg.png" data-alt="" data-width="28" data-height="28" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/42px-Industry5.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/56px-Industry5.svg.png 2x" data-class="noviewer"> </span></span><span><a href="/wiki/Portal:Companies" title="Portal:Companies">Companies portal</a></span></li></ul></div>
<ul><li><i><a href="/wiki/Kirin-Amgen_v_Hoechst_Marion_Roussel" class="mw-redirect" title="Kirin-Amgen v Hoechst Marion Roussel">Kirin-Amgen v Hoechst Marion Roussel</a></i>, a <a href="/wiki/United_Kingdom" title="United Kingdom">UK</a> <a href="/wiki/Patent" title="Patent">patent</a> case decided by the <a href="/wiki/House_of_Lords" title="House of Lords">House of Lords</a></li>
<li><i><a href="/wiki/Amgen_Inc._v._Harris" class="mw-redirect" title="Amgen Inc. v. Harris">Amgen Inc. v. Harris</a></i>, a United States Supreme Court case on employment law.</li>
<li><a href="/wiki/Evolocumab" title="Evolocumab">Evolocumab</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=9" title="Edit section: References" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-Snapshotfinancials2018-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-Snapshotfinancials2018_1-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://investors.amgen.com/phoenix.zhtml?c=61656&amp;p=irol-fundSnapshot">"Amgen 2018 Financials Snapshot"</a>. <i>amgen.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+2018+Financials+Snapshot&amp;rft_id=http%3A%2F%2Finvestors.amgen.com%2Fphoenix.zhtml%3Fc%3D61656%26p%3Dirol-fundSnapshot&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-PMfinancials2018-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMfinancials2018_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMfinancials2018_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.amgen.com/media/news-releases/2019/01/amgen-reports-fourth-quarter-and-full-year-2018-financial-results/">"Amgen Reports Fourth Quarter And Full Year 2018 Financial Results (PM Jan. 29, 2019)"</a>. <i>amgen.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 May</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+Reports+Fourth+Quarter+And+Full+Year+2018+Financial+Results+%28PM+Jan.+29%2C+2019%29&amp;rft_id=https%3A%2F%2Fwww.amgen.com%2Fmedia%2Fnews-releases%2F2019%2F01%2Famgen-reports-fourth-quarter-and-full-year-2018-financial-results%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-filings2016-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-filings2016_3-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://investors.amgen.com/phoenix.zhtml?c=61656&amp;p=irol-secText&amp;TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMzk2OTIxJkRTRVE9MSZTRVE9JlNRREVTQz1TRUNUSU9OX0JPRFkmZXhwPSZzdWJzaWQ9NTc%3d#s68A6077D72B15AFD883671586243760A">"Amgen 2016 SEC Filings 10-K"</a>. <i>amgen.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 July</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+2016+SEC+Filings+10-K&amp;rft_id=http%3A%2F%2Finvestors.amgen.com%2Fphoenix.zhtml%3Fc%3D61656%26p%3Dirol-secText%26TEXT%3DaHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMzk2OTIxJkRTRVE9MSZTRVE9JlNRREVTQz1TRUNUSU9OX0JPRFkmZXhwPSZzdWJzaWQ9NTc%253d%23s68A6077D72B15AFD883671586243760A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-quickfacts2020-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-quickfacts2020_4-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://wwwext.amgen.com/~/media/amgen/full/www-amgen-com/downloads/fact-sheets/fact_sheet_amgen.ashx">"About Amgen Fact Sheet"</a>. <i>amgen.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=About+Amgen+Fact+Sheet&amp;rft_id=https%3A%2F%2Fwwwext.amgen.com%2F~%2Fmedia%2Famgen%2Ffull%2Fwww-amgen-com%2Fdownloads%2Ffact-sheets%2Ffact_sheet_amgen.ashx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.amgenhistory.com/">Amgen History official site</a> page accessed January 2, 2016</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text">Ronald Vogel. Pharmaceutical Economics and Public Policy. CRC Press, 2007. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9781439801345" title="Special:BookSources/9781439801345">9781439801345</a>. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=ejNC3HJmjhwC&amp;pg=PA208#v=onepage&amp;q&amp;f=false">P. 208</a></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text">Bidwell, Carol A. (1989). <i>The Conejo Valley: Old and New Frontiers</i>. Windsor Publications. Page 128. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780897812993" title="Special:BookSources/9780897812993">9780897812993</a>.</span>
</li>
<li id="cite_note-Baker,_Pam_2002_Page_37-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Baker,_Pam_2002_Page_37_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Baker,_Pam_2002_Page_37_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Baker, Pam (2002). <i>Thousand Oaks Westlake Village: A Contemporary Portrait</i>. Community Communications, Inc. Page 37. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1581920611" title="Special:BookSources/978-1581920611">978-1581920611</a>.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.toaks.org/home/showdocument?id=17130">http://www.toaks.org/home/showdocument?id=17130</a> (Page 162).</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><cite class="citation web">February 16, Acorn Staff; 2018 (16 February 2018). <a rel="nofollow" class="external text" href="https://www.mpacorn.com/articles/biotech-giant-amgen-has-big-plans-for-new-plant/">"Biotech giant Amgen has big plans for new plant"</a>. <i>Moorpark Acorn</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Moorpark+Acorn&amp;rft.atitle=Biotech+giant+Amgen+has+big+plans+for+new+plant&amp;rft.date=2018-02-16&amp;rft.aulast=February+16&amp;rft.aufirst=Acorn+Staff&amp;rft.au=2018&amp;rft_id=https%3A%2F%2Fwww.mpacorn.com%2Farticles%2Fbiotech-giant-amgen-has-big-plans-for-new-plant%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text">Bidwell, Carol A. (1989). <i>The Conejo Valley: Old and New Frontiers</i>. Windsor Publications. Pages 128–129. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/9780897812993" title="Special:BookSources/9780897812993">9780897812993</a>.</span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.amgentourofcalifornia.com/">"AMGEN TOUR OF CALIFORNIA"</a>. <i>Amgen Tour of California</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-02-07</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Amgen+Tour+of+California&amp;rft.atitle=AMGEN+TOUR+OF+CALIFORNIA&amp;rft_id=https%3A%2F%2Fwww.amgentourofcalifornia.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Mar-1998-10-K-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Mar-1998-10-K_13-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/237/31815498000003/filing-main.htm">"Amgen, Form 10-K, Annual Report, Filing Date Mar 24, 1998"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+10-K%2C+Annual+Report%2C+Filing+Date+Mar+24%2C+1998&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F237%2F31815498000003%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Mar-2000-10-K405-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Mar-2000-10-K405_14-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/227/89843000000676/filing-main.htm">"Amgen, Form 10-K405, Filing Date Mar 7, 2000"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+10-K405%2C+Filing+Date+Mar+7%2C+2000&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F227%2F89843000000676%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-May-2012-8-K-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-May-2012-8-K_15-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/1218/119312512245437/filing-main.htm">"Amgen, Form 8-K, Current Report, Filing Date May 24, 2012"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+May+24%2C+2012&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F1218%2F119312512245437%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.marsdd.com/mars-library/amgen-a-biotechnology-success-story-from-drug-development-to-the-mass-market/">"Amgen—A biotechnology success story | From drug development to the mass market"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%E2%80%94A+biotechnology+success+story+%7C+From+drug+development+to+the+mass+market&amp;rft_id=https%3A%2F%2Fwww.marsdd.com%2Fmars-library%2Famgen-a-biotechnology-success-story-from-drug-development-to-the-mass-market%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-auto-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-auto_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-auto_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=103795&amp;DrugName=ENBREL&amp;ActiveIngred=ETANERCEPT&amp;SponsorApplicant=IMMUNEX&amp;ProductMktStatus=1&amp;goto=Search.DrugDetails">"Drugs@FDA: FDA Approved Drug Products"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drugs%40FDA%3A+FDA+Approved+Drug+Products&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.Set_Current_Drug%26ApplNo%3D103795%26DrugName%3DENBREL%26ActiveIngred%3DETANERCEPT%26SponsorApplicant%3DIMMUNEX%26ProductMktStatus%3D1%26goto%3DSearch.DrugDetails&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=103353&amp;DrugName=NEUPOGEN&amp;ActiveIngred=FILGRASTIM&amp;SponsorApplicant=AMGEN&amp;ProductMktStatus=1&amp;goto=Search.DrugDetails">"Drugs@FDA: FDA Approved Drug Products"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drugs%40FDA%3A+FDA+Approved+Drug+Products&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.Set_Current_Drug%26ApplNo%3D103353%26DrugName%3DNEUPOGEN%26ActiveIngred%3DFILGRASTIM%26SponsorApplicant%3DAMGEN%26ProductMktStatus%3D1%26goto%3DSearch.DrugDetails&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation journal">Lyman GH, Kuderer NM, Djulbegovic B (April 2002). "Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis". <i>Am. J. Med</i>. <b>112</b> (5): 406–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0002-9343%2802%2901036-7">10.1016/s0002-9343(02)01036-7</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11904116">11904116</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Med.&amp;rft.atitle=Prophylactic+granulocyte+colony-stimulating+factor+in+patients+receiving+dose-intensive+cancer+chemotherapy%3A+a+meta-analysis&amp;rft.volume=112&amp;rft.issue=5&amp;rft.pages=406-11&amp;rft.date=2002-04&amp;rft_id=info%3Adoi%2F10.1016%2Fs0002-9343%2802%2901036-7&amp;rft_id=info%3Apmid%2F11904116&amp;rft.aulast=Lyman&amp;rft.aufirst=GH&amp;rft.au=Kuderer%2C+NM&amp;rft.au=Djulbegovic%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation journal">Chen YF, Jobanputra P, Barton P,  et al. (November 2006). "A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness". <i>Health Technol Assess</i>. <b>10</b> (42): iii–iv, xi–xiii, 1–229. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3310%2Fhta10420">10.3310/hta10420</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17049139">17049139</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+Technol+Assess&amp;rft.atitle=A+systematic+review+of+the+effectiveness+of+adalimumab%2C+etanercept+and+infliximab+for+the+treatment+of+rheumatoid+arthritis+in+adults+and+an+economic+evaluation+of+their+cost-effectiveness&amp;rft.volume=10&amp;rft.issue=42&amp;rft.pages=iii-iv%2C+xi-xiii%2C+1-229&amp;rft.date=2006-11&amp;rft_id=info%3Adoi%2F10.3310%2Fhta10420&amp;rft_id=info%3Apmid%2F17049139&amp;rft.aulast=Chen&amp;rft.aufirst=YF&amp;rft.au=Jobanputra%2C+P&amp;rft.au=Barton%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation journal">Morgan CL, Emery P, Porter D,  et al. (January 2014). "Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data". <i>Rheumatology (Oxford)</i>. <b>53</b> (1): 186–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Frheumatology%2Fket333">10.1093/rheumatology/ket333</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24140761">24140761</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Rheumatology+%28Oxford%29&amp;rft.atitle=Treatment+of+rheumatoid+arthritis+with+etanercept+with+reference+to+disease-modifying+anti-rheumatic+drugs%3A+long-term+safety+and+survival+using+prospective%2C+observational+data&amp;rft.volume=53&amp;rft.issue=1&amp;rft.pages=186-94&amp;rft.date=2014-01&amp;rft_id=info%3Adoi%2F10.1093%2Frheumatology%2Fket333&amp;rft_id=info%3Apmid%2F24140761&amp;rft.aulast=Morgan&amp;rft.aufirst=CL&amp;rft.au=Emery%2C+P&amp;rft.au=Porter%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=125320&amp;DrugName=PROLIA&amp;ActiveIngred=DENOSUMAB&amp;SponsorApplicant=AMGEN&amp;ProductMktStatus=1&amp;goto=Search.Label_ApprovalHistory">"Drugs@FDA: FDA Approved Drug Products"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drugs%40FDA%3A+FDA+Approved+Drug+Products&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcder%2Fdrugsatfda%2Findex.cfm%3Ffuseaction%3DSearch.Set_Current_Drug%26ApplNo%3D125320%26DrugName%3DPROLIA%26ActiveIngred%3DDENOSUMAB%26SponsorApplicant%3DAMGEN%26ProductMktStatus%3D1%26goto%3DSearch.Label_ApprovalHistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125320s0000lbl.pdf">"www.accessdata.fda.gov"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=www.accessdata.fda.gov&amp;rft_id=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F125320s0000lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm234346.htm">"FDA approves Xgeva to help prevent cancer-related bone injury"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+Xgeva+to+help+prevent+cancer-related+bone+injury&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm234346.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation news">Terhune, Chad (18 December 2012). <a rel="nofollow" class="external text" href="https://articles.latimes.com/2012/dec/18/business/la-fi-amgen-plea-20121219">"Amgen pleads guilty to improper marketing of anemia drug Aranesp"</a>. Los Angeles Times<span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Amgen+pleads+guilty+to+improper+marketing+of+anemia+drug+Aranesp&amp;rft.date=2012-12-18&amp;rft.aulast=Terhune&amp;rft.aufirst=Chad&amp;rft_id=https%3A%2F%2Farticles.latimes.com%2F2012%2Fdec%2F18%2Fbusiness%2Fla-fi-amgen-plea-20121219&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation news">Husten, Larry. <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/larryhusten/2012/12/18/amgen-pleads-guilty-to-misbranding-anemia-drug-aranesp/">"Amgen Pleads Guilty To Misbranding Anemia Drug Aranesp"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=Amgen+Pleads+Guilty+To+Misbranding+Anemia+Drug+Aranesp&amp;rft.aulast=Husten&amp;rft.aufirst=Larry&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2012%2F12%2F18%2Famgen-pleads-guilty-to-misbranding-anemia-drug-aranesp%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.pharmatimes.com/Article/13-01-17/Amgen_s_Aranesp_fails_in_heart_trial_Singapore_plant_planned.aspx">"Article &gt; Amgen's Aranesp fails in heart trial, Singapore plant planned"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Article+%3E+Amgen%27s+Aranesp+fails+in+heart+trial%2C+Singapore+plant+planned&amp;rft_id=http%3A%2F%2Fwww.pharmatimes.com%2FArticle%2F13-01-17%2FAmgen_s_Aranesp_fails_in_heart_trial_Singapore_plant_planned.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation news">Lipton, Eric (19 January 2013). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2013/01/20/us/medicare-pricing-delay-is-political-win-for-amgen-drug-maker.html?pagewanted=all">"Fiscal Footnote: Big Senate Gift to Drug Maker"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York+Times&amp;rft.atitle=Fiscal+Footnote%3A+Big+Senate+Gift+to+Drug+Maker&amp;rft.date=2013-01-19&amp;rft.aulast=Lipton&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2013%2F01%2F20%2Fus%2Fmedicare-pricing-delay-is-political-win-for-amgen-drug-maker.html%3Fpagewanted%3Dall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.huffingtonpost.com/jon-entine/after-congressional-budge_b_2759676.html">"Jon Entine: New York Times Mum After Congressional Budget Office Rebukes Bungled Amgen/Medicare Investigation"</a>. <i>Huffington Post</i>. 26 February 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Huffington+Post&amp;rft.atitle=Jon+Entine%3A+New+York+Times+Mum+After+Congressional+Budget+Office+Rebukes+Bungled+Amgen%2FMedicare+Investigation&amp;rft.date=2013-02-26&amp;rft_id=https%3A%2F%2Fwww.huffingtonpost.com%2Fjon-entine%2Fafter-congressional-budge_b_2759676.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130605171126/http://www.nephrologynews.com/articles/109331-cbo-analysis-shows-keeping-oral-drugs-out-of-esrd-bundle-could-save-money">"CBO analysis shows keeping oral drugs out of ESRD bundle could save money | Nephrology News &amp; Issues"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.nephrologynews.com/articles/109331-cbo-analysis-shows-keeping-oral-drugs-out-of-esrd-bundle-could-save-money">the original</a> on 2013-06-05.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CBO+analysis+shows+keeping+oral+drugs+out+of+ESRD+bundle+could+save+money+%26%23124%3B+Nephrology+News+%26+Issues&amp;rft_id=http%3A%2F%2Fwww.nephrologynews.com%2Farticles%2F109331-cbo-analysis-shows-keeping-oral-drugs-out-of-esrd-bundle-could-save-money&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-genengnews.com-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-genengnews.com_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-genengnews.com_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/for-up-to-1-55b-amgen-acquires-dezima-pharma/81251735/">"For Up to $1.55B, Amgen Acquires Dezima Pharma"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=For+Up+to+%241.55B%2C+Amgen+Acquires+Dezima+Pharma&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Ffor-up-to-1-55b-amgen-acquires-dezima-pharma%2F81251735%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/amgen-bets-17b-xencors-antibody-technology/2015-09-16">"Amgen bets up to $1.7B on Xencor's antibody technology"</a>. <i>FierceBiotech</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FierceBiotech&amp;rft.atitle=Amgen+bets+up+to+%241.7B+on+Xencor%27s+antibody+technology&amp;rft_id=http%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Famgen-bets-17b-xencors-antibody-technology%2F2015-09-16&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/amgen-xencor-to-partner-on-cancer-immunotherapy-inflammation-drugs/81251734/">"Amgen, Xencor to Partner on Cancer Immunotherapy, Inflammation Drugs"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Amgen%2C+Xencor+to+Partner+on+Cancer+Immunotherapy%2C+Inflammation+Drugs&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Famgen-xencor-to-partner-on-cancer-immunotherapy-inflammation-drugs%2F81251734%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/amgen-buys-rights-to-myeloma-bite-immunotherapy-from-boehringer-ingelheim/81253166/">"Amgen Buys Rights to Myeloma BiTE Immunotherapy from Boehringer Ingelheim - GEN News Highlights - GEN"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen+Buys+Rights+to+Myeloma+BiTE+Immunotherapy+from+Boehringer+Ingelheim+-+GEN+News+Highlights+-+GEN&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Famgen-buys-rights-to-myeloma-bite-immunotherapy-from-boehringer-ingelheim%2F81253166%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.amgen.com/media/news-releases/2018/02/amgen-reports-fourth-quarter-and-full-year-2017-financial-results/">"Amgen Reports Fourth Quarter And Full Year 2017 Financial Results"</a>. <i>www.amgen.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-05-14</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.amgen.com&amp;rft.atitle=Amgen+Reports+Fourth+Quarter+And+Full+Year+2017+Financial+Results&amp;rft_id=https%3A%2F%2Fwww.amgen.com%2Fmedia%2Fnews-releases%2F2018%2F02%2Famgen-reports-fourth-quarter-and-full-year-2017-financial-results%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/fortune500/amgen/">"Fortune 500 company by revenue 2018 cial"</a>. <i>www.fortune.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-03-18</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.fortune.com&amp;rft.atitle=Fortune+500+company+by+revenue+2018+cial&amp;rft_id=http%3A%2F%2Ffortune.com%2Ffortune500%2Famgen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-nuevolution-m-a-amgen-idUKKCN1SS0OC">"Amgen to buy Copenhagen-based Nuevolution for $167 million"</a>. 22 May 2019 – via uk.reuters.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen+to+buy+Copenhagen-based+Nuevolution+for+%24167+million&amp;rft.date=2019-05-22&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-nuevolution-m-a-amgen-idUKKCN1SS0OC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/amgen-to-acquire-otezla-for-13-4-billion-in-cash-or-approximately-11-2-billion-net-of-anticipated-future-cash-tax-benefits/?s=79">https://www.biospace.com/article/releases/amgen-to-acquire-otezla-for-13-4-billion-in-cash-or-approximately-11-2-billion-net-of-anticipated-future-cash-tax-benefits/?s=79</a></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://uk.reuters.com/article/us-bristol-myers-divestiture-amgen/celgene-to-sell-psoriasis-drug-otezla-for-13-4-billion-to-amgen-idUKKCN1VG102">https://uk.reuters.com/article/us-bristol-myers-divestiture-amgen/celgene-to-sell-psoriasis-drug-otezla-for-13-4-billion-to-amgen-idUKKCN1VG102</a></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.statnews.com/2019/10/31/amgen-acquires-stake-in-beigene-to-expand-cancer-drug-business-to-china/">https://www.statnews.com/2019/10/31/amgen-acquires-stake-in-beigene-to-expand-cancer-drug-business-to-china/</a></span>
</li>
<li id="cite_note-Amgen-Feb-1995-8-K/A-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Feb-1995-8-K/A_41-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/2236/31815495000003/filing-main.htm">"Amgen, Form 8-K/A, Filing Date Feb 2, 1995"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2FA%2C+Filing+Date+Feb+2%2C+1995&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F2236%2F31815495000003%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Oct-2000-425-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Oct-2000-425_42-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/2565/89843000003014/filing-main.htm">"Amgen, Form 425, Filing Date Oct 16, 2000"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+425%2C+Filing+Date+Oct+16%2C+2000&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F2565%2F89843000003014%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Dec-2001-8-K-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Dec-2001-8-K_43-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/970/89843001503918/filing-main.htm">"Amgen, Form 8-K, Current Report, Filing Date Dec 17, 2001"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Dec+17%2C+2001&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F970%2F89843001503918%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.amgen.com/media/media_pr_detail.jsp?year=2002&amp;releaseID=515163">"Amgen - Media - News Release"</a>. <i>amgen.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+-+Media+-+News+Release&amp;rft_id=http%3A%2F%2Fwww.amgen.com%2Fmedia%2Fmedia_pr_detail.jsp%3Fyear%3D2002%26releaseID%3D515163&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Mar-2004-8-K-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Mar-2004-8-K_45-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/1479/0001193125-04-052430.pdf">"Amgen, Form 8-K, Current Report, Filing Date Mar 29, 2004"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Mar+29%2C+2004&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F1479%2F0001193125-04-052430.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Dec-2005-8-K-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Dec-2005-8-K_46-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/2313/0001104659-05-060878.pdf">"Amgen, Form 8-K, Current Report, Filing Date Dec 15, 2005"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Dec+15%2C+2005&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F2313%2F0001104659-05-060878.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Apr-2006-8-K-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Apr-2006-8-K_47-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/2579/0001193125-06-086852.pdf">"Amgen, Form 8-K, Current Report, Filing Date Apr 24, 2006"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Apr+24%2C+2006&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F2579%2F0001193125-06-086852.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://wwwext.amgen.com/media/media_pr_detail.jsp?year=2006&amp;releaseID=837754">"Amgen - Media - News Release"</a>. <i>amgen.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+-+Media+-+News+Release&amp;rft_id=http%3A%2F%2Fwwwext.amgen.com%2Fmedia%2Fmedia_pr_detail.jsp%3Fyear%3D2006%26releaseID%3D837754&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Sep-2006-8-K-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Sep-2006-8-K_49-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/1246/119312506199481/filing-main.htm">"Amgen, Form 8-K, Current Report, Filing Date Sep 29, 2006"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Sep+29%2C+2006&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F1246%2F119312506199481%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://wwwext.amgen.com/media/media_pr_detail.jsp?year=2007&amp;releaseID=1012256">"Amgen - Media - News Release"</a>. <i>amgen.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=amgen.com&amp;rft.atitle=Amgen+-+Media+-+News+Release&amp;rft_id=http%3A%2F%2Fwwwext.amgen.com%2Fmedia%2Fmedia_pr_detail.jsp%3Fyear%3D2007%26releaseID%3D1012256&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Aug-2007-10-Q-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-Amgen-Aug-2007-10-Q_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Amgen-Aug-2007-10-Q_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/233/0001193125-07-176142.pdf">"Amgen, Form 10-Q, Quarterly Report, Filing Date Aug 9, 2007"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+10-Q%2C+Quarterly+Report%2C+Filing+Date+Aug+9%2C+2007&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F233%2F0001193125-07-176142.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Jan-2011-8-K-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Jan-2011-8-K_52-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://edgar.secdatabase.com/1618/119312511013248/filing-main.htm">"Amgen, Form 8-K, Current Report, Filing Date Jan 25, 2011"</a>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Jan+25%2C+2011&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fedgar.secdatabase.com%2F1618%2F119312511013248%2Ffiling-main.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-May-2011-10-Q-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-May-2011-10-Q_53-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/2865/0000950123-11-048073.pdf">"Amgen, Form 10-Q, Quarterly Report, Filing Date May 10, 2011"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+10-Q%2C+Quarterly+Report%2C+Filing+Date+May+10%2C+2011&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F2865%2F0000950123-11-048073.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Jan-2012-8-K-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Jan-2012-8-K_54-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/2009/0001193125-12-024302.pdf">"Amgen, Form 8-K, Current Report, Filing Date Jan 26, 2012"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Jan+26%2C+2012&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F2009%2F0001193125-12-024302.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-Apr-2012-8-K-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-Apr-2012-8-K_55-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/1634/0001193125-12-191871.pdf">"Amgen, Form 8-K, Current Report, Filing Date Apr 30, 2012"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+8-K%2C+Current+Report%2C+Filing+Date+Apr+30%2C+2012&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F1634%2F0001193125-12-191871.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.hurriyet.com.tr/ekonomi/20415671.asp">"Türk ilaç devi 700 milyon dolara satýldý"</a>. <i>hurriyet.com.tr</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=hurriyet.com.tr&amp;rft.atitle=T%C3%BCrk+ila%C3%A7+devi+700+milyon+dolara+sat%C3%BDld%C3%BD&amp;rft_id=http%3A%2F%2Fwww.hurriyet.com.tr%2Fekonomi%2F20415671.asp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-Amgen-May-2012-10-Q-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-Amgen-May-2012-10-Q_57-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://pdf.secdatabase.com/2053/0001193125-12-216282.pdf">"Amgen, Form 10-Q, Quarterly Report, Filing Date May 8, 2012"</a> <span class="cs1-format">(PDF)</span>. secdatabase.com<span class="reference-accessdate">. Retrieved <span class="nowrap">Jan 8,</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen%2C+Form+10-Q%2C+Quarterly+Report%2C+Filing+Date+May+8%2C+2012&amp;rft.pub=secdatabase.com&amp;rft_id=http%3A%2F%2Fpdf.secdatabase.com%2F2053%2F0001193125-12-216282.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><cite class="citation journal">Guha, Malini (October 8, 2013). "Amgen swallows Onyx whole". <i>Nature Biotechnology</i>. <b>31</b> (10): 859–860. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnbt1013-859">10.1038/nbt1013-859</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24104731">24104731</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Biotechnology&amp;rft.atitle=Amgen+swallows+Onyx+whole&amp;rft.volume=31&amp;rft.issue=10&amp;rft.pages=859-860&amp;rft.date=2013-10-08&amp;rft_id=info%3Adoi%2F10.1038%2Fnbt1013-859&amp;rft_id=info%3Apmid%2F24104731&amp;rft.aulast=Guha&amp;rft.aufirst=Malini&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/amgen-acquires-catherex-spin-off-from-medigene/81252129/">"Amgen acquires Catherex Spin-off from Medigene - GEN News Highlights - GEN"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Amgen+acquires+Catherex+Spin-off+from+Medigene+-+GEN+News+Highlights+-+GEN&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Famgen-acquires-catherex-spin-off-from-medigene%2F81252129%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text">Food and Drug Administration December 3, 2014 <a rel="nofollow" class="external text" href="https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm425597.htm">FDA Press release: Blinatumomab</a></span>
</li>
<li id="cite_note-BiovitriumDeal-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-BiovitriumDeal_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BiovitriumDeal_61-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BiovitriumDeal_61-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Amgen press office. <a rel="nofollow" class="external text" href="http://www.amgen.com/media/biovitrum_amgen_deal.html">Biovitrum Closes Product Acquisition Deal with Amgen</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120703015728/http://www.amgen.com/media/biovitrum_amgen_deal.html">Archived</a> July 3, 2012, at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20131230232434/http://www.sobi.com/en/Healthcare-Professionals/Products-alphabetical-list/Stemgen/">"Stemgen® (ancestim)"</a>. <i>sobi.com</i>. Archived from <a rel="nofollow" class="external text" href="http://www.sobi.com/en/Healthcare-Professionals/Products-alphabetical-list/Stemgen/">the original</a> on 2013-12-30<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-12-30</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=sobi.com&amp;rft.atitle=Stemgen%C2%AE+%28ancestim%29&amp;rft_id=http%3A%2F%2Fwww.sobi.com%2Fen%2FHealthcare-Professionals%2FProducts-alphabetical-list%2FStemgen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.amgen.com/science/pipe.html">Amgen Phase III Pipeline</a>, accessed December 29, 2013</span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/amgen-halts-rilotumumab-trials-in-advanced-gastric-cancer/81250637/">"GEN - News Highlights:Amgen Halts Rilotumumab Trials in Advanced Gastric Cancer"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3AAmgen+Halts+Rilotumumab+Trials+in+Advanced+Gastric+Cancer&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Famgen-halts-rilotumumab-trials-in-advanced-gastric-cancer%2F81250637%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/brodalumab-s-no-turkey-in-phase-iii-amgen-and-astrazeneca/81250645/">"GEN - News Highlights:Brodalumab's No Turkey in Phase III: Amgen and AstraZeneca"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3ABrodalumab%27s+No+Turkey+in+Phase+III%3A+Amgen+and+AstraZeneca&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbrodalumab-s-no-turkey-in-phase-iii-amgen-and-astrazeneca%2F81250645%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/celimmune-licenses-amgen-s-amg-714-for-celiac-disease/81250980/">"GEN - News Highlights:Celimmune Licenses Amgen's AMG 714 for Celiac Disease"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+-+News+Highlights%3ACelimmune+Licenses+Amgen%27s+AMG+714+for+Celiac+Disease&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fcelimmune-licenses-amgen-s-amg-714-for-celiac-disease%2F81250980%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-June2015-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-June2015_67-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.medscape.com/viewarticle/846893">"New Data on CGRP Monoclonal Antibodies for Migraine Prevention"</a>. <i>Medscape</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medscape&amp;rft.atitle=New+Data+on+CGRP+Monoclonal+Antibodies+for+Migraine+Prevention&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F846893&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation news">Lisa Astor (September 9, 2019). <a rel="nofollow" class="external text" href="https://www.targetedonc.com/news/fda-grants-amg-510-fast-track-designation-for-kras-g12c-nsclc">"FDA Grants AMG 510 Fast Track Designation for KRAS G12C+ NSCLC"</a>. targetedonc.com<span class="reference-accessdate">. Retrieved <span class="nowrap">November 16,</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=FDA+Grants+AMG+510+Fast+Track+Designation+for+KRAS+G12C%2B+NSCLC&amp;rft.date=2019-09-09&amp;rft.au=Lisa+Astor&amp;rft_id=https%3A%2F%2Fwww.targetedonc.com%2Fnews%2Ffda-grants-amg-510-fast-track-designation-for-kras-g12c-nsclc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAmgen" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Amgen&amp;action=edit&amp;section=10" title="Edit section: External links" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Amgen" class="extiw" title="commons:Category:Amgen"><span style="">Amgen</span></a></b></i>.</td></tr></tbody></table><ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.amgen.com/">Official website</a></span></span></li>
<li>Business data for Amgen: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=AMGN">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=AMGN">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=AMGN">SEC filings</a></li></ul></div></li>
<li><a rel="nofollow" class="external text" href="http://www.secdatabase.com/CIK/318154/Company-Name/AMGEN-INC">Amgen SEC Filings</a></li>
<li><a rel="nofollow" class="external text" href="http://finance.google.com/finance?q=amgn&amp;btnG=Search">Amgen Inc. Company Profile</a> at <a href="/wiki/Google_Finance" title="Google Finance">Google Finance</a></li>
<li><a rel="nofollow" class="external text" href="https://stockrow.com/AMGN">AMGN on Stockrow</a></li></ul>





</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Amgen&amp;oldid=950859604">https://en.wikipedia.org/w/index.php?title=Amgen&amp;oldid=950859604</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Amgen"
				data-user-name="OAbot"
				data-user-gender="unknown"
				data-timestamp="1586845783">
				<span>Last edited on 14 April 2020, at 06:29</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Amgen&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.896","walltime":"1.127","ppvisitednodes":{"value":4807,"limit":1000000},"postexpandincludesize":{"value":241138,"limit":2097152},"templateargumentsize":{"value":5938,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":3,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":224079,"limit":5000000},"entityaccesscount":{"value":2,"limit":400},"timingprofile":["100.00%  943.228      1 -total"," 43.58%  411.025      1 Template:Reflist"," 25.71%  242.494     47 Template:Cite_web"," 23.23%  219.136      1 Template:Infobox_company"," 21.71%  204.801      1 Template:Infobox","  8.93%   84.271      8 Template:Wikidata","  8.79%   82.901      1 Template:Br_separated_entries","  7.37%   69.517      1 Template:CladeR","  6.27%   59.171      1 Template:Clade_sequential","  5.96%   56.260      1 Template:Short_description"]},"scribunto":{"limitreport-timeusage":{"value":"0.455","limit":"10.000"},"limitreport-memusage":{"value":8433585,"limit":52428800}},"cachereport":{"origin":"mw1333","timestamp":"20200417052534","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Amgen","url":"https:\/\/en.wikipedia.org\/wiki\/Amgen","sameAs":"http:\/\/www.wikidata.org\/entity\/Q470517","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q470517","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-08-26T19:49:34Z","dateModified":"2020-04-14T06:29:43Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/3\/3e\/Amgenheadquarters.jpg","headline":"American multinational biopharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":137,"wgHostname":"mw1372"});});</script>		</body>
		</html>
		